October 31, 2016 Health and Biotech analytics news roundup

Here’s the latest in health and biotech analytics:

23andMe Has Given Up On Next-Generation Sequencing: The company is defying current trends and abandoning tests based on whole-genome sequencing. Instead, they’re focusing on their current business, which only examines specific portions of the genome.

Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with Watson: The companies are looking for systematic ways of discovering new ways to use drugs that are already approved for use. They are also working on ways to proactively manage chronic conditions like asthma.

The Johns Hopkins Hospital Launches Capacity Command Center to Enhance Hospital Operations: The center employs 24 people tracking real-time data. It has made many areas of the hospital’s operations, like transferring and discharging patients, more efficient.

Right-Sizing Your Long-Term Computational Needs for Life Sciences Workloads: Michael McManus, Senior Health and Life Sciences Solution Architect at Intel, discusses how companies can use workflow and storage ‘rate constants’ to know how much computing they need and how to scale it up. He also discusses cluster architecture specifically tailored to sequencing, which can make the workflow more efficient.

 

Source by pstein

Leave a Reply

Your email address will not be published. Required fields are marked *